Kinetics of the graft-versus-leukemia response after donor leukocyte infusions for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation

Blood

Volumn 92, Issue 10, 1998, Pages 3582-3590

  Baurmann, Herrad ^a,b   Nagel, Stefan ^a   Binder, Thomas ^a   Neubauer, Andreas ^a   Siegert, Wolfgang ^a   Huhn, Dieter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

ADOPTIVE IMMUNOTHERAPY; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHIMERA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROPOIESIS; FEMALE; GRAFT VERSUS LEUKEMIA EFFECT; GRANULOPOIESIS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKOCYTE TRANSFUSION; LYMPHOPOIESIS; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032533591     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3582     Document Type: Article

References (33)

1. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobson N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Witte T, Haller E, Ansari H: Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86:2041, 1995
2. Collins RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, Goodman SA, Wolff SN, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin JH, Nemunaitis J: Donor leukocyte infuions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 15:433, 1997
3. Siegert W, Beyer J, Kingreen D, Blaszcyk R, Baurmann H, Schwella N, Schleicher J, Kirsch A, Huhn D: Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated C-CSF mobilized peripheral blood stem cell preparation. Bone Marrow Transplant 22:579, 1998
4. Weber-Matthiesen K, Winkemann M, Müller-Hermelink A, Schlegelberger BGW: Simultaneous fluorescence immunophenotyping and interphase cytogenetics: A contribution to the characterization of tumor cells. J Histochem Cytochem 40:171, 1992
5. Baurmann H, Cherif D, Berger R: Interphase cytogenetics by fluorescent in situ hybridization (FISH) for characterization of monosomy-7-associated disorders. Leukemia 7:384, 1993
6. + Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 86:1464, 1995
7. Nagel S, Schmidt M, Thiede C, Huhn D, Neubauer A: Quantification of Bcr-Abl transcripts in chronic myeloid leukemia (CML) using standardized, internally controlled, competitive differential PCR (CD-PCR). Nucleic Acids Res 24:4102, 1996
8. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1987
9. Budowle B, Lindsey JA, DeCou JA, Koons BW, Giusti AM, Comey CT: Validation and population studies of the loci LDLR, GYPA, HBGG, D7S8, and GC (PM loci), and HLA-DQ alpha using a multiplex amplification and typing procedure. J Forensic Sci 40:45, 1995
10. Fildes N, Reynolds R: Consistency and reproducibility of AmpliType PM results between seven laboratories: Field trial results. J Forensic Sci 40:279, 1995
11. Flowers ME, Sullivan KM, Martin P, Bruckner CD, Beach K, Higano T, Radich J, Clift R, Bensinger W, Deeg HJ, Chauncey T, Rowley S, Storb R, Appelbaum F: G-CSF stimulated donor peripheral blood infusions as immunotherapy in patients with hematologic malignancies relapsing after allogeneic transplantation. Blood 86:564a, 1995 (abstr, suppl 1)
12. Glass B, Majolino I, Dreger P, Scimè R, Santoro A, Varta S, Suttorp M, Haferlach T, Schmitz N: Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation. Bone Marrow Transplant 20:533, 1997
13. Cross NCP, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM: Competitive polymerase chain reaction to estimate the number of bcr-abl transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 82:1929, 1993
14. Schmidt M, Nagel S, Proba J, Thiede C, Ritter M, Waring JF, Rosenbauer F, Huhn D, Wittig B, Horak I, Neubauer A: Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood 91:22, 1998
15. Bertheas MF, Maraninchi D, Lafage M, Fraisse J, Blaise D, Stoppa AM, Michel G, Brizard CP, Gaspard MH, Novakovitch G, Mannoni P, Viens P, Carcassonne Y: Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: A cytogenetic documentation. Blood 72:89, 1988
16. Bertheas MF, Lafage M, Lewy P, Blaise D, Stoppa AM, Viens P, Mannoni P, Maraninchi D: Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia. Blood 78: 3103, 1991
17. van Leeuwen JEM, van Tol MJD, Joosten AM, Wijnen JT, Meera Kann P, Vossen JM: Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse. Blood 82:1921, 1993
18. Suttorp M, Schmitz N, Dreger P, Schaub J, Löffler H: Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphism. Leukemia 7:679, 1993
19. Mackinnon S, Barnett L, Heller G, O'Reilly RJ: Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogeneous leukemia. Blood 83:3409, 1994
20. Socié G, Lawler M, Gluckman E, McCann SR, Brison O: Studies on hematopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology era (review). Leuk Res 19:497, 1995
21. Palla G, Stuppis L, Di Bartolomeo P, Morizio E, Peila R, Guanciali Franchi P, Calabrese G: FISH detection of mixed chimerism in 33 pts submitted to bone marrow transplantation. Bone Marrow Transplant 17:231, 1996
22. Huss R, Deeg HJ, Gooly T, Bryant E, Leisenring W, Clift R, Buckner CD, Martin P, Storb R, Appelbaum FR: Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogeneous leukemia. Bone Marrow Transplant 18:767, 1996
23. Ramírez M, Díaz MA, García-Sánchez F, Velasco M, Casado F, Villa M, Vicario JL, Madero L: Chimerism after allogeneic hematopoietic cell transplantation in childhood lymphoblastic leukemia. Bone Marrow Transplant 18:1161, 1996
24. Bader P, Höller W, Klingebiel T, Handgretinger R, Benda N, Schlegel PG, Niethammer D, Beck J: Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: The impact of quantitative PCR analysis for prediction of relapse and graft rejection in children. Bone Marrow Transplant 19:697, 1997
25. Lapointe C, Forest L, Lussier P, Busque L, Lagace F, Perreault C, Roy D-C, Gyger M: Sequential analysis of early hematopoietic reconstitution following allogeneic bone marrow transplantation with fluorescence in situ hybridization (FISH). Bone Marrow Transplant 17:1143, 1996
26. Kögler G, Wolf HH, Heyll A, Arkesteijn, Wernet P: Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leukocytes by fluorescent in situ hybridization in combination with the simultaneous analysis of interphase cells. Bone Marrow Transplant 15:41, 1995
27. van Rhee F, Liu F, Cullis JO, Spencer A, Cross NCP, Chase A, Caricochea B, Bungey J, Barett J, Goldman JM: Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 83:3377, 1994
28. Truitt RL, Atasoylu AA: Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation. Blood 77:2515, 1991
29. Garicochea B, Chase A, Lazaridou A, Goldman JM: T-lymphocytes in CML: No evidence of BCR-ABL fusion gene detected by fluorescence in situ hybridization in 14 patients. Leukemia 8:1197, 1994
30. Haferlach T, Winkemann M, Nickenig C, Meeder M, Ramm-Petersen L, Schoch R, Nickelsen M, Weber-Matthiesen K, Schlegelberger B, Schoch C, Gassmann W, Löffler H: Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukemia? An answer at the single cell level by combining May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques. Br J Haematol 97:99, 1997
31. Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F, Castro-Malaspina H, Childs BH, Gillio AP, Kernan NA, Small TN, Young JW, O'Reilly RJ: Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 86:1261, 1995
32. Rapanotti MC, Arcese W, Buffolino S, Iori AP, Mengarelli A, Cuia MR, Cardillo A, Cimino G: Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusions for relapse after bone marrow transplantation. Bone Marrow Transplant 19:703, 1997
33. Keil F, Haas OA, Fritsch G, Jalhs P, Lechner K, Mannhalter C, Reiter E, Niederwieser D, Hoecker P, Greinix HAT: Donor leukocyte infusion for leukemic relapse after allogeneic marow transplantation: Lack of residual donor hematopoiesis predicts aplasia. Blood 89:3113, 1997